CardioDx in the News
August 08, 2012Fierce Medical Devices
CardioDx nailed down reimbursement from a major Medicare contractor for its coronary artery disease blood-based test, a significant and potentially lucrative milestone for the California-based, cardiovascular genomic diagnostics company.
December 14, 2011Diagnostic and Interventional Cardiology
The results of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) trial were presented at the American Heart Association Scientific Sessions 2011 conference in Orlando, Fla.
November 15, 2011Xconomy
November 15, 2011UPI.com
A blood test is more effective to rule out obstructive coronary artery disease than a test that uses a radioactive agent, U.S. researchers say.
November 15, 2011Fierce Medical Devices
CardioDx saw good news from Florida this week with the presentation of results from the COMPASS Study involving Corus CAD, a blood-based gene expression test for obstructive coronary artery disease.
September 19, 2011San Francisco Business Times
A veteran Bay Area biotech chief financial officer and a former investment bank analyst have joined CardioDx Inc. in senior management jobs.
June 17, 2011Forbes.com
A few weeks ago a local politician in my area died of a massive heart attack at 49, while on a lighthearted ski weekend in Tahoe with his buddies.
May 18, 2011Pharmacogenomics Reporter
CardioDx has raised $60 million in equity financing that it will invest in expanding reimbursement for its Corus CAD genetic test for coronary artery disease.
February 07, 2011Ivanhoe Today
Every 35 seconds, an America dies of heart disease. If your family has a history of heart attacks or stroke, you are twice as likely to have one yourself.
January 21, 2011Medscape Today
A Best Evidence Interview With Eric J. Topol, MD
A free Medscape account is required to view article.